Takeda Pharmaceutical Company (TAK) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Takeda Pharmaceutical Company Limited has issued a 5.300% senior note due in 2034, with a principal amount of $500 million. The note is a global note, subject to Japanese withholding tax unless held by certain entities exempted for tax purposes, and it will pay semi-annual interest starting from January 5, 2025. Payments on non-business days will be processed the next business day without additional interest for the delay.
For further insights into TAK stock, check out TipRanks’ Stock Analysis page.
